Farrell unloads ResMed stock
By HME News Staff
Updated Tue May 6, 2014
SAN DIEGO - Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares of company stock on the open market in a transaction dated May 1. The stock was sold at $49.80 for a total value of $1.245 million. Farrell still owns 304,990 shares in the company valued at $15.188 million. The sale was disclosed in a document filed with the Securities & Exchange Commission.
Comments